Serum IL-21 levels decrease with glucocorticoid treatment in myasthenia gravis

Neurological Sciences

Volumn 35, Issue 1, 2014, Pages 29-34

  Li, Y ^a   Rauniyar, V K ^a,b   Yin, W F ^a   Hu, B ^a   Ouyang, S ^a,c   Xiao, B ^a   Yang, H ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b KATHMANDU UNIVERSITY   (Nepal)

^c Department of Neurology   (China)

Author keywords

Anti AchR antibody; Glucocorticoid treatment; Interleukin 21; Myasthenia gravis

Indexed keywords

GLUCOCORTICOID; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; IMMUNOGLOBULIN G3; INTERLEUKIN 21; INTERLEUKIN 21 RECEPTOR; MESSENGER RNA;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOSTEROID THERAPY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; MALE; MIDDLE AGED; MYASTHENIA GRAVIS; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; AUTOANTIBODIES; AUTOANTIGENS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GLUCOCORTICOIDS; HUMANS; IMMUNOGLOBULIN G; INTERLEUKINS; MALE; MIDDLE AGED; MYASTHENIA GRAVIS; RECEPTORS, CHOLINERGIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84892676916     PISSN: 15901874     EISSN: 15903478     Source Type: Journal    
DOI: 10.1007/s10072-013-1460-3     Document Type: Article

References (27)

1. Conti-Fine BM, Milani M, Kaminski HJ (2006) Myasthenia gravis: past, present, and future. J Clin Invest 116(11):2843-2854 (Pubitemid 44684466)
2. + T cells and cytokines in the pathogenesis of acquired myasthenia gravis. Ann N Y Acad Sci 1132:193-209 (Pubitemid 351858541)
3. Parrish-Novak J, Dillon SR, Nelson A et al (2000) Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function. Nature 408:57-63
4. Kim HP, Korn LL, Gamero AM et al (2005) Calcium-dependent activation of interleukin-21 gene expression in T cells. J Biol Chem 280:25291-25297 (Pubitemid 40934624)
5. Spolski R, Leonard WJ (2008) Interleukin-21: basic biology and implications for cancer and autoimmunity. Annu Rev Immunol 26:57-79 (Pubitemid 351600371)
6. Ozaki K, Kikly K, Michalovich D et al (2000) Cloning of a type I cytokine receptor most related to the IL-2 receptor beta chain. Proc Natl Acad Sci USA 97:11439-11444
7. Liu R, Bai Y, Vollmer TL et al (2008) IL-21 receptor expression determines the temporal phases of experimental autoimmune encephalomyelitis. Exp Neurol 211:14-24
8. Vollmer TL, Liu R, Price M et al (2005) Differential effects of IL-21 during initiation and progression of autoimmunity against neuroantigen. J Immunol 174(5):2696-2701 (Pubitemid 40279684)
9. Kasahara TM, Teixeira B, Ferreira TB et al (2013) The ex vivo production of IL-6 and IL-21 by CD4(+) T cells is directly associated with neurological disability in neuromyelitis optica patients. J Clin Immunol 33:179-189
10. Hohlfeld R, Toyka KV, Heininger K (1984) Autoimmune human T lymphocyte specific for acetylcholine receptor. Nature 310:244-246 (Pubitemid 14090716)
11. Wang W, Milani M, Ostlie N et al (2007) C57BL/6 mice genetically deficient in IL-12/IL-23 and IFN-gamma are susceptible to experimental autoimmune myasthenia gravis, suggesting a pathogenic role of non-Th1 cells. J Immunol 178(11):7072-7080 (Pubitemid 46847433)
12. Yang H, Zhang Y, Wu M et al (2010) Suppression of ongoing experimental autoimmune myasthenia gravis by transfer of RelB-silenced bone marrow dendritic cells is associated with a change from a T helper Th17/Th1 to a Th2 and FoxP3 + regulatory T-cell profile. Inflamm Res 59(3):197-205
13. Masuda M, Matsumoto M, Tanaka S et al (2010) Clinical implication of peripheral CD4+ CD25+ regulatory T cells and Th17 cells in myasthenia gravis patients. J Neuroimmunol 225(1-2):123-131
14. Hu B, Tian X, Huang H et al (2010) Expression of IL-21 in the peripheral blood of myasthenia gravis patients and its correlation with anti-AChR-Ab class switch. Zhong Nan Da Xue Xue Bao Yi Xue Ban 35(9):958-963 Chinese
15. Furukawa Y, Yoshikawa H, Iwasa K et al (2008) Clinical efficacy and cytokine network-modulating effects of tacrolimus in myasthenia gravis. J Neuroimmunol 195(1-2):108-115
16. Spolski R, Leonard WJ (2008) The Yin and Yang of interleukin-21 in allergy, autoimmunity and cancer. Curr Opin Immunol 20(3):295-301
17. Ozaki K, Spolski R, Ettinger R et al (2004) Regulation of B cell differentiation and plasma cell generation by IL-21, a novel inducer of Blimp-1 and Bcl-6. J Immunol 173:5361-5371 (Pubitemid 39392119)
18. Vinuesa CG, Cook MC, Angelucci C et al (2005) A RING-type ubiquitin ligase family member required to repress follicular helper T cells and autoimmunity. Nature 435:452-458 (Pubitemid 40734237)
19. Wang XF, Yuan SL, Jiang L et al (2007) Changes of serum BAFF and IL-21 levels in patients with systemic lupus erythematosus and their clinical significance. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 23(11):1041-1042 Chinese
20. Wong CK, Wong PT, Tam LS et al (2010) Elevated production of B cell chemokine CXCL13 is correlated with systemic lupus erythematosus disease activity. J Clin Immunol 30(1):45-52
21. Rasmussen TK, Andersen T, Hvid M et al (2010) Increased interleukin 21 (IL-21) and IL-23 are associated with increased disease activity and with radiographic status in patients with early rheumatoid arthritis. J Rheumatol 37(10):2014-2020
22. Meriggioli MN, Sanders DB (2009) Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity. Lancet Neurol 8(5):475-490
23. Coutinho AE, Chapman KE (2011) The anti-inflammatory and immunosuppressive effects of glucocorticoids, recent developments and mechanistic insights. Mol Cell Endocrinol 335(1):2-13
24. + T-cells. Immunol Lett 131(1):24-32
25. Stary G, Klein I, Bauer W et al (2011) Glucocorticosteroids modify Langerhans cells to produce TGF-β and expand regulatory T cells. J Immunol 186(1):103-112
26. Momcilović M, Miljković Z, Popadić D et al (2008) Methylprednisolone inhibits interleukin-17 and interferon-gamma expression by both naive and primed T cells. BMC Immunol 9:47
27. Jüngel A, Distler JH, Kurowska-Stolarska M et al (2004) Expression of interleukin-21 receptor, but not interleukin-21, in synovial fibroblasts and synovial macrophages of patients with rheumatoid arthritis. Arthritis Rheum 50(5):1468-1476 (Pubitemid 38608068)